%0 Journal Article
%T Direct oral anticoagulants for stroke prevention in atrial
fibrillation: treatment outcomes and dosing in special
populations
%A Sara K. Richter
%A Zachary A. Stacy
%J Archive of "Therapeutic Advances in Cardiovascular Disease".
%D 2018
%R 10.1177/1753944718787384
%X To review data from the pivotal phase III trials evaluating the efficacy and safety of direct oral anticoagulants (DOACs) versus warfarin for stroke prevention in patients with nonvalvular atrial fibrillation (NVAF), and to summarize the major findings with regards to patient subgroups that are at an increased risk for stroke or bleeding
%K direct oral anticoagulants
%K dosing recommendations
%K nonvalvular atrial fibrillation
%K special populations
%K stroke prevention
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6116754/